Investment
Features
FeesSafety
Academy
More
Pluang+

BorgWarner schedules webcast for Q3 2026 earnings on Oct 29 at 9:30am ET

Company Fundamentals
22 Sep 2026
PRNewsWire
View Source
Neutral
BorgWarner schedules webcast for Q3 2026 earnings on Oct 29 at 9:30am ET

BorgWarner Inc. announced a webcast for its third quarter 2026 earnings results, scheduled for October 29, 2026, at 9:30am Eastern Time. Investors and interested parties can access the live webcast via the company's investor website. The call will also be archived for later viewing. This event provides insight into BorgWarner's financial performance and ongoing commitment to sustainable mobility innovation.

BorgWarner 2026 Q3 webcast alert provides context for Industrials sector data on Pluang. For readers following Industrials, here is Pluang's market snapshot as of Sep 23, 2026 01:22 WIB: 53 of 92 US Industrials stocks rose, 39 fell. Lockheed Martin (LMT) traded at USD 518.80 with a 1-day change of -3.10% and 100% buy order activity. American Superconductor (AMSC) rose 3.09% to USD 31.18, typical hold time 29 days. Enovix (ENVX) increased 3.02% to USD 3.07, with 99% sell order activity and a 10-day hold time.

More News

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech's phase II trial shows 61.3% 12-month survival in refractory metastatic colorectal cancer with vilamakitug.

XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...

Company Fundamentals
Bullish
1 hour ago
Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

Phase II study shows Vilamakitug improves 12-month survival in refractory metastatic colorectal cancer.

XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...

Market News
Bullish
1 hour ago
Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals to acquire 4,300 net royalty acres in North Dakota's Williston Basin

Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...

Company Fundamentals
Bullish
2 hours ago
Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

Hershey Trust sells shares ahead of Q3 earnings, retaining control amid price hikes and volume drop.

The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...

Market News
Neutral
3 hours ago
W. R. Berkley Q3 2026 earnings beat EPS estimates but revenue dips, net income down 13%.

W. R. Berkley Q3 2026 earnings beat EPS estimates but revenue dips, net income down 13%.

W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App